Assignee
PHARMACYCLICS LLC
US65 patents
Top patents by PatentIndex Score
US9409911B2Aug 9, 2016
Inhibitors of bruton's tyrosine kinase
PHARMACYCLICS LLC42 citations99
US9266893B2Feb 23, 2016
Inhibitors of Bruton's tyrosine kinase
PHARMACYCLICS LLC40 citations99
US9296753B2Mar 29, 2016
Crystalline forms of a Bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC84 citations98
US10125140B1Nov 13, 2018
Crystalline forms of a bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC18 citations97
US9725455B1Aug 8, 2017
Crystalline forms of a bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC25 citations97
US9713617B2Jul 25, 2017
Crystalline forms of a Bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC28 citations97
US9540382B2Jan 10, 2017
Crystalline forms of a Bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC43 citations97
US9828383B1Nov 28, 2017
Crystalline forms of a bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC20 citations95
US9655857B2May 23, 2017
Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC32 citations95
US10478439B2Nov 19, 2019
Use of inhibitors of bruton's tyrosine kinase (Btk)
PHARMACYCLICS LLC8 citations93
US10294232B2May 21, 2019
Crystalline forms of a Bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC9 citations92
US10294231B2May 21, 2019
Crystalline forms of a Bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC11 citations92
US10106548B2Oct 23, 2018
Crystalline forms of a Bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC13 citations92
US10065968B2Sep 4, 2018
Crystalline forms of a bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC10 citations92
US10016435B2Jul 10, 2018
Use of inhibitors of Bruton's tyrosine kinase (Btk)
PHARMACYCLICS LLC12 citations92
US10004745B2Jun 26, 2018
Use of inhibitors of Bruton'S tyrosine kinase (Btk)
PHARMACYCLICS LLC7 citations92
US10004746B2Jun 26, 2018
Use of inhibitors of Bruton's tyrosine kinase (Btk)
PHARMACYCLICS LLC9 citations92
US9814721B2Nov 14, 2017
Use of inhibitors of bruton'S tyrosine kinase (BTK)
PHARMACYCLICS LLC14 citations92
US9801883B2Oct 31, 2017
Use of inhibitors of bruton's tyrosine kinase (Btk)
PHARMACYCLICS LLC11 citations92
US9801881B2Oct 31, 2017
Use of inhibitors of bruton's tyrosine kinase (BTK)
PHARMACYCLICS LLC13 citations92
US9556182B2Jan 31, 2017
Inhibitors of Bruton's tyrosine kinase
PHARMACYCLICS LLC11 citations92
US9540385B2Jan 10, 2017
Pyrrolopyrimidine compounds as kinase inhibitors
PHARMACYCLICS LLC18 citations92
US9415050B2Aug 16, 2016
Methods for the treatment of HER2 amplified cancer
PHARMACYCLICS LLC17 citations92
US10213386B2Feb 26, 2019
Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC18 citations91
US10010507B1Jul 3, 2018
Pharmaceutical formulations of a bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC23 citations91
US9795604B2Oct 24, 2017
Methods of treating and preventing graft versus host disease
PHARMACYCLICS LLC19 citations89
US9545407B2Jan 17, 2017
Formulations of a bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC51 citations86
US11672803B2Jun 13, 2023
Use of inhibitors of Brutons tyrosine kinase (Btk)
PHARMACYCLICS LLC2 citations84
US10961251B1Mar 30, 2021
Crystalline forms of a Bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC4 citations84
US10752634B2Aug 25, 2020
Crystalline forms of a brutons tyrosine kinase inhibitor
PHARMACYCLICS LLC3 citations84
US10751342B2Aug 25, 2020
Use of inhibitors of Bruton's tyrosine kinase (Btk)
PHARMACYCLICS LLC5 citations84
US10653696B2May 19, 2020
Use of inhibitors of bruton's tyrosine kinase (BTK)
PHARMACYCLICS LLC5 citations84
US10266540B2Apr 23, 2019
Crystalline forms of a Bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC5 citations84
US9795605B2Oct 24, 2017
Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors
PHARMACYCLICS LLC6 citations84
US9421208B2Aug 23, 2016
Methods for the treatment of solid tumors
PHARMACYCLICS LLC7 citations84
US10828259B2Nov 10, 2020
Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC5 citations81
US10695350B2Jun 30, 2020
Methods of treating and preventing graft versus host disease
PHARMACYCLICS LLC6 citations81
US10463668B2Nov 5, 2019
Methods of treating and preventing graft versus host disease
PHARMACYCLICS LLC8 citations81
US9717731B2Aug 1, 2017
TEC family kinase inhibitor adjuvant therapy
PHARMACYCLICS LLC14 citations80
US9885086B2Feb 6, 2018
Phospholipase C gamma 2 and resistance associated mutations
PHARMACYCLICS LLC8 citations76
US9730938B2Aug 15, 2017
Bruton's tyrosine kinase inhibitor combinations and uses thereof
PHARMACYCLICS LLC16 citations75
US10105552B2Oct 23, 2018
Formulations of histone deacetylase inhibitor and uses thereof
PHARMACYCLICS LLC2 citations73
US10016434B2Jul 10, 2018
Methods for the treatment of HER2 amplified cancer
PHARMACYCLICS LLC2 citations73
US9862722B2Jan 9, 2018
Inhibitors of Bruton's tyrosine kinase
PHARMACYCLICS LLC4 citations73
US9724349B2Aug 8, 2017
Methods for the treatment of HER2 amplified cancer
PHARMACYCLICS LLC2 citations73
US9637487B2May 2, 2017
Purinone compounds as kinase inhibitors
PHARMACYCLICS LLC6 citations73
US9624224B2Apr 18, 2017
Inhibitors of Bruton's tyrosine kinase
PHARMACYCLICS LLC6 citations73
US9533991B2Jan 3, 2017
Inhibitors of Bruton's tyrosine kinase
PHARMACYCLICS LLC3 citations73
US9403032B2Aug 2, 2016
Formulations of histone deacetylase inhibitor and uses therof
PHARMACYCLICS LLC3 citations73
US9469642B2Oct 18, 2016
Purinone compounds as kinase inhibitors
PHARMACYCLICS LLC4 citations72
Showing the top 50 of 65 patents by PatentIndex Score.